Fluticasone Spray Competition Grows With Perrigo Launch Of West-Ward Product
This article was originally published in The Tan Sheet
Executive Summary
FDA approves Hikma Pharmaceuticals subsidiary West-Ward Pharmaceuticals' ANDA for fluticasone propionate/0.05mg per spray and Perrigo is shipping the generic equivalent of Flonase Allergy Relief to retailers and distributors.
You may also be interested in...
GSK Rides Cold, Flu And Pain OTCs In Q4 While Allergy Carries Sanofi
Firm's "power brands" in respiratory and pain areas achieved high single-digit sales growth in the fourth quarter on an “earlier and more severe” cold season that also drove overall consumer health sales in the period up 4.3% to $2.65bn.
GSK Rides Cold, Flu And Pain OTCs In Q4 While Allergy Carries Sanofi
Firm's "power brands" in respiratory and pain areas achieved high single-digit sales growth in the fourth quarter on an “earlier and more severe” cold season that also drove overall consumer health sales in the period up 4.3% to $2.65bn.
OTCs Launched On Fluticasone ANDAs, Lidocaine In Monograph
Innovus entering OTC fluticasone market in November; and Rising Biosciences prepares topical OTC pain relief.